Author

Asher Rajkumar Rajan

University of Nebraska Medical CenterORCID 0000-0002-7763-7160Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Benjamin B. KennedyiD· 3 shared Hamid BandiD· 3 shared M. Jordan RowleyiD· 3 shared Vimla BandiD· 3 shared Bhopal C. MohapatraiD· 2 shared Farshid OrujiiD· 2 shared Mohsin Raza· 2 shared Sameer MirzaiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Benjamin B. KennedyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A novel RNA-binding activity of ECD contributes to U5 snRNP stability and pre-mRNA splicing

Mohsin Raza, Asher Rajkumar Rajan, Achyuth Kalluchi, Bhopal Mohapatra, Irfana Saleem, Benjamin B. Kennedy, Kishor K. Bhakat, Hamid Band, M. Jordan Rowley, Vimla Band

This study identifies ECD's RNA-binding activity and shows it stabilizes U5 snRNP and is essential for pre-mRNA splicing.

Nucleic Acids Research · Jul 11, 2026Peer-reviewedCell Biology

ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis

Mohsin Raza, Asher Rajkumar Rajan, Benjamin B. Kennedy, Timothy E. Reznicek, Farshid Oruji, Sameer Mirza, M. Jordan Rowley, Carsten Stephan, Glen Kristiansen, Kaustubh Datta, Bhopal C. Mohapatra, Hamid Band, Vimla Band

This study identifies ECD as a novel androgen receptor target that promotes prostate cancer by enhancing glycolysis and oncogenic traits.

Oncogene · Sep 4, 2025Peer-reviewedCancer Biology

ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis

Benjamin B. Kennedy, Mohsin Raza, Sameer Mirza, Asher Rajkumar Rajan, Farshid Oruji, Matthew D. Storck, Subodh M. Lele, Timothy E. Reznicek, Lusheng Li, M. Jordan Rowley, Shibiao Wan, Bhopal C. Mohapatra, Hamid Band, Vimla Band

This study shows ECD and ERBB2 cooperate in breast cancer by enhancing unfolded protein response and glycolysis through direct mRNA binding and increased glucose uptake.

Cancer Letters · Jul 28, 2025Peer-reviewedCancer Biology